article thumbnail

NHC Submits Comments on CMS’ Proposed Rule on Marketplace Integrity and Affordability

Putting Patients First Blog

While we recognize CMS intent to strengthen program integrity and reduce fraud, we are deeply concerned that several provisions in this rule will create obstacles to coverage, increase out-of-pocket costs, and disproportionately impact vulnerable populations.

article thumbnail

A Review of Oral Cephalosporins for Common Outpatient Infections

Pharmacy Times

First-generation oral cephalosporins (ie, cephalexin and cefadroxil) have excellent coverage of methicillin-susceptible S aureus and Streptococcus spp, making them ideal agents for treatment. Typically, empiric coverage for UTIs includes Escherichia coli and Klebsiella pneumoniae.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Caveat Emptor in the Gray Market

Pharmaceutical Commerce

2 The following cases underscore the importance of diligence and vigilance in our procurement processes. Undoubtedly, the most significant recent case involving counterfeit drugs infiltrating the legitimate US supply chain was the 2021–2023 Gilead HIV medications case. April 14, 2025.

article thumbnail

Medicaid’s Role in the CGT Sector

Pharmaceutical Commerce

Back in 2021, an estimated 1,582,062 Medicaid recipients were estimated to have at least one out of 379 rare diseases. Peer-reviewed articles and federal reports—among other publications—were used to support their findings addressing safety, effectiveness, payment, accountability, and access in the process.

article thumbnail

From data to impact: How real-world evidence will transform healthcare

pharmaphorum

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

80 health IT & revenue cycle up-and-comers | 2025

Beckers Hospital Review

Mr. Angelone, co-founder and chief commercial officer of MacroHealth, has over 25 years of experience in the health insurance and technology industries. Mr. Angelone has also ensured compliance with key regulations like the No Surprises Act and Transparency in Coverage rules, promoting greater transparency in healthcare pricing.

article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

It’s important that the biosimilar market continue to build on the success established last year in 2021. Based on this momentum, we’re making three predictions for 2021: we will see increased competition within individual markets pay off, expansion in the biosimilar channel to include new therapeutic categories, and more regulatory support.